| Primary |
| Hypertension |
72.7% |
| Essential Hypertension |
13.6% |
| Atrioventricular Septal Defect |
4.5% |
| Cardiac Failure |
4.5% |
| Renal Cancer |
4.5% |
|
| Hyponatraemia |
11.5% |
| Renal Failure Acute |
11.5% |
| Death |
7.7% |
| Syncope |
7.7% |
| Androgenetic Alopecia |
3.8% |
| Angioedema |
3.8% |
| Hyperkalaemia |
3.8% |
| Hypovolaemia |
3.8% |
| Listless |
3.8% |
| Malignant Melanoma |
3.8% |
| Myalgia |
3.8% |
| Oedema Mucosal |
3.8% |
| Pneumonia |
3.8% |
| Post Viral Fatigue Syndrome |
3.8% |
| Product Substitution Issue |
3.8% |
| Reaction To Colouring |
3.8% |
| Renal Failure |
3.8% |
| Retinal Detachment |
3.8% |
| Somnolence |
3.8% |
| Swollen Tongue |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
45.2% |
| Hypertension |
28.8% |
| Epilepsy |
5.5% |
| Essential Hypertension |
5.5% |
| Atrioventricular Septal Defect |
2.7% |
| Diabetes Mellitus |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Abdominal Pain Upper |
1.4% |
| Cardiovascular Disorder |
1.4% |
| Gastric Infection |
1.4% |
| Oedema |
1.4% |
| Osteoporosis |
1.4% |
|
| Hyponatraemia |
28.6% |
| Somnolence |
14.3% |
| Insomnia |
7.1% |
| Oligohydramnios |
7.1% |
| Reaction To Colouring |
7.1% |
| Androgenetic Alopecia |
3.6% |
| Concussion |
3.6% |
| Hypertension |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Listless |
3.6% |
| Myalgia |
3.6% |
| Post Viral Fatigue Syndrome |
3.6% |
| Premature Baby |
3.6% |
| Product Substitution Issue |
3.6% |
| Scar |
3.6% |
|
| Concomitant |
| Hypertension |
24.0% |
| Product Used For Unknown Indication |
22.7% |
| Diabetes Mellitus |
7.4% |
| Rheumatoid Arthritis |
7.4% |
| Atrial Fibrillation |
4.1% |
| Hypercholesterolaemia |
3.7% |
| Hepatitis C |
3.3% |
| Ankylosing Spondylitis |
2.5% |
| Hepatic Neoplasm Malignant |
2.5% |
| Prophylaxis |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Angina Pectoris |
2.1% |
| Depression |
2.1% |
| Fibromyalgia |
2.1% |
| Her-2 Positive Breast Cancer |
2.1% |
| Prostate Cancer |
2.1% |
| Psoriasis |
2.1% |
| Back Pain |
1.7% |
| Breast Cancer |
1.7% |
| Bronchitis |
1.7% |
|
| Hepatic Failure |
7.1% |
| Renal Failure Acute |
7.1% |
| Subileus |
7.1% |
| Vomiting |
7.1% |
| Dehydration |
4.8% |
| Drug Ineffective |
4.8% |
| Haematochezia |
4.8% |
| Myalgia |
4.8% |
| Nausea |
4.8% |
| Pyrexia |
4.8% |
| Renal Failure |
4.8% |
| Spinal Fracture |
4.8% |
| Sudden Cardiac Death |
4.8% |
| Tinnitus |
4.8% |
| Urinary Retention |
4.8% |
| Urticaria |
4.8% |
| Weight Decreased |
4.8% |
| Weight Increased |
4.8% |
| Blood Glucose Increased |
2.4% |
| Cardiopulmonary Failure |
2.4% |
|
| Interacting |
| Convulsion |
33.3% |
| Hypertension |
33.3% |
| Prophylaxis |
33.3% |
|
| General Physical Health Deterioration |
25.0% |
| Hyponatraemia |
25.0% |
| Toxicity To Various Agents |
25.0% |
| Tremor |
25.0% |
|
